AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Free cash flow, 2025
- −$94M
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | −$94M | — |
| 2024 | −$129M | — |
| 2023 | −$146M | — |
| 2022 | −$117M | — |
| 2021 | −$109M | — |
| 2020 | −$79M | — |
| 2019 | −$46M | — |
| 2018 | −$30M | — |
| 2017 | −$26M | — |
| 2016 | −$21M | — |
| 2015 | −$7.5M | — |